MELA Sciences

MELA Sciences is a medical device company focused on the design, development and commercialization of non-invasive tools to provide

Business Model:

Revenue: $0

Employees: 51-200

Rankings

Detailed MELA Sciences Information

Geographic Data

MELA Sciences headquarters map

Address:

City: Irvington

State: New York

Zip:

Country: United States

Financial Info

Stage:

post ipo debt

Raised Last:

$10M

Raised Total:

$42M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

MELA Sciences is a medical technology company dedicated to designing and developing innovative software-driven technologies that assist physicians during the clinical evaluation and detection of skin cancer. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.

Contact Phone:

Contact Email:

MELA Sciences went public on 10/28/2005 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/28/2005

Ticker Symbol:
MELA

IPO Price:
$5/share

Amount Raised:
$20M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2014 Post-IPO Debt 1 $20M Hercules Capital
Hercules Capital
1/2015 Post-IPO Debt 1 $10M Hercules Capital
Hercules Capital
2/2014 Post-IPO Equity $12M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research